Reaction
Primary Mediastinal Large B-Cell Lymphoma reporting signals
As of the last recalculation, Primary Mediastinal Large B-Cell Lymphoma appears in 117 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is AXICABTAGENE CILOLEUCEL (PRR 663.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Axicabtagene Ciloleucel | 28 | 663.2 | 665.1 |
| Polatuzumab Vedotin | 8 | 156.5 | 156.6 |
| Bendamustine Hcl | 7 | 85.3 | 85.4 |
| Brentuximab Vedotin | 4 | 71.8 | 71.9 |